APA (7th ed.) Citation

Li, M., Liu, X., Xie, Y., Tang, X., Song, L., Zhao, F., . . . Zhu, T. (2024). Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK. European Journal of Pharmacology, 965, N.PAG. https://doi.org/10.1016/j.ejphar.2024.176315

Chicago Style (17th ed.) Citation

Li, Ming-hui, et al. "Sodium Butyrate Alleviates Right Ventricular Hypertrophy in Pulmonary Arterial Hypertension by Inhibiting H19 and Affecting the Activation of Let-7g-5p/IGF1 Receptor/ERK." European Journal of Pharmacology 965 (2024): N.PAG. https://doi.org/10.1016/j.ejphar.2024.176315.

MLA (9th ed.) Citation

Li, Ming-hui, et al. "Sodium Butyrate Alleviates Right Ventricular Hypertrophy in Pulmonary Arterial Hypertension by Inhibiting H19 and Affecting the Activation of Let-7g-5p/IGF1 Receptor/ERK." European Journal of Pharmacology, vol. 965, 2024, p. N.PAG, https://doi.org/10.1016/j.ejphar.2024.176315.